Vaccination against hepatitis viruses in Poland

被引:10
作者
Slusarczyk, J [1 ]
机构
[1] Natl Inst Hyg, Dept Sera & Vaccines Evaluat, PL-00791 Warsaw, Poland
关键词
hepatitis viruses; Poland; vaccination;
D O I
10.1016/S0264-410X(00)00459-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
At present, two etiologic varieties of viral hepatitis (VH) can be directly vaccine-preventable: VH type A and VH type B. In addition. VH type D can be prevented indirectly through vaccination against VH-B. The first commercially available vaccine against VH-B appeared in 1981 and was human plasma-derived. After several years it has generally been replaced by a recombinant type of vaccines. The obvious benefits of vaccination against VH-B prompted its introduction into the national immunization program in Poland in 1989. At that time. vaccination was offered free of charge to high-risk groups: newborns of HBsAg-carrier mothers, health-care workers, students: at medical schools, nursing schools, medical technology schools, and caretakers at institutions for mentally retarded persons. However, similarly to the experiences of other countries. observations in Poland indicated that such a targeted strategy fails to induce major epidemiological changes. In 1989 and in 1993, the incidence of VH-B per 100 000 was 40.3 and 34.6, respectively. In addition. during these years, the incidence of V-B per 100 000 children aged 0-4 years was 20.0 and 38.4. respectively. It has been decided that vaccination against VH-B will be obligatory for all newborns beginning from 1993. Due to financial constraints, it has been introduced in three phases, and since 1996, all newborns in Poland have been vaccinated. Already in 1993, three additional risk groups have been offered vaccination: patients with chronic diseases, patients awaiting planned surgery, and persons coming into close contact with acute VH-B or chronically HBV-infected individuals. In 1999, the incidence of VH-B per 100 000 was 9.1/100 000, and it may be assumed that vaccination helped to decrease the incidence of VH-B in Poland. The country experience with vaccination against VH-A is still limited. At present, it is recommended for children and adolescents and people dealing with food distribution, as well as for several other groups of people, such as travellers or long-term visitors (soldiers, missionaries, diplomats) to the endemic regions of the world. It has also been recommended in connection with natural disasters such as floods occurring in a large area of Poland in 1997. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2384 / 2388
页数:5
相关论文
共 50 条
[31]   Epidemiological Impact of Mandatory Vaccination against Hepatitis B in Italian Young Adults [J].
Campagna, Marcello ;
Siddu, Andrea ;
Meloni, Angelo ;
Murru, Claudia ;
Masia, Giuseppina ;
Coppola, Rosa Cristina .
HEPATITIS MONTHLY, 2011, 11 (09) :750-752
[32]   Exploring the optimal vaccination strategy against hepatitis B virus in childhood (Review) [J].
Kramvis, Anna ;
Mammas, Ioannis N. ;
Spandidos, Demetrios A. .
BIOMEDICAL REPORTS, 2023, 19 (01)
[33]   Vaccination Campaign against Hepatitis B Virus in Italy: A History of Successful Achievements [J].
Stroffolini, Tommaso ;
Stroffolini, Giacomo .
VACCINES, 2023, 11 (10)
[34]   Is vaccination against hepatitis B a reality among Primary Health Care workers? [J].
da Costa, Fernanda Marques ;
de Barros Lima Martins, Andrea Maria Eleuterio ;
dos Santos Neto, Pedro Eleuterio ;
de Pinho Veloso, Duran Nunes ;
Magalhaes, Vilma Soares ;
Ferreira, Raquel Conceicao .
REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2013, 21 (01) :316-324
[35]   Twenty years of universal vaccination against hepatitis B in Italy: achievements and challenges [J].
Romano, Luisa ;
Paladini, Sara ;
Zanetti, Alessandro R. .
JOURNAL OF PUBLIC HEALTH RESEARCH, 2012, 1 (02) :126-129
[36]   Comparison of the accelerated and standard vaccination schedules against hepatitis B in healthcare workers [J].
Ghadiri, Keyghobad ;
Vaziri, Siavash ;
Afsharian, Mandana ;
Jahanbaksh, Alireza ;
Mansouri, Faizolah ;
Sayad, Babak ;
Najafi, Farid ;
Souri, Bahram .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (10) :934-937
[37]   Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease [J].
de Artaza Varasa, Tomas ;
Sanchez Ruano, Juan Jose ;
Garcia Vela, Almudena ;
Gomez Rodriguez, Rafael ;
Romero Gutierrez, Marta ;
de la Cruz Perez, Gema ;
Gomez Moreno, Ana Zaida ;
Carrobles Jimenez, Jose Maria .
GASTROENTEROLOGIA Y HEPATOLOGIA, 2009, 32 (07) :483-488
[38]   Impact of universal childhood vaccination against hepatitis B in Ghana: A pilot study [J].
Hagan, Oheneba C. K. ;
Nsiah, Paul ;
Obiri-Yeboah, Dorcas ;
Yirdong, Felix ;
Annan, Isaac ;
Eliason, Sebastian ;
Nuvor, Samuel V. .
JOURNAL OF PUBLIC HEALTH IN AFRICA, 2018, 9 (02) :92-95
[39]   Comparison of the accelarated and classic vaccination schedules against Hepatitis B: Three-week Hepatitis B vaccination schedule provides immediate and protective immunity [J].
Nese Saltoğlu ;
A Seza Inal ;
Yesim Tasova ;
Ozlem Kandemir .
Annals of Clinical Microbiology and Antimicrobials, 2 (1)
[40]   Vaccination Against Human Papilloma Viruses Leads to a Favorable Cytokine Profile of Specific T Cells [J].
Luckau, Stefanie ;
Wehrs, Tim P. ;
Brandau, Sven ;
Horn, Peter A. ;
Lindemann, Monika .
JOURNAL OF IMMUNOTHERAPY, 2016, 39 (08) :316-320